New stent valve offers hope for rare heart condition patients
NCT ID NCT05064514
First seen May 10, 2026 · Last updated May 16, 2026 · Updated 2 times
Summary
This study tests a special stent valve (TRICENTO) in 15 people with carcinoid heart disease who have a leaky tricuspid valve and cannot have open-heart surgery. The goal is to see if the implant reduces the leak and improves symptoms and quality of life. Participants will be followed for safety and effectiveness.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CARCINOID SYNDROME are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Barts Health NHS Trust
London, England, E1 1BB, United Kingdom
Conditions
Explore the condition pages connected to this study.